
- July 2012 Digestive Health
- Volume 78
- Issue 7
Flying Increases Risk of IBD Flares
Flying to high altitudes may increase the risk of inflammatory bowel disease (IBD) flares, according to research presented at the 2012 Digestive Disease Week.
Investigators, led by Stephan Vavricka, MD, chief of the division of gastroenterology and hepatology at Triemli Hospital in Zurich, studied 103 patients who were seen at several IBD clinics in Switzerland over a period of 1 year. Both groups were asked about their activities during the previous 4 weeks through retrospective questionnaires. Fifty-two recently relapsed IBD patients were matched with 51 IBD patients in remission and the 2 patient groups were controlled for factors such as age, smoking, sports activities, and recent antibiotic treatment. IBD patients with flares reported traveling to heights of at least 2000 meters (6562 feet) during the study period more frequently compared with patients in remission (40.4% versus 15.7%, respectively). When broken down by IBD type, Crohn’s disease patients were found to have a higher risk of flare than ulcerative colitis patients.
Prior evidence has shown that oxygen depletion, or hypoxia, induces elevated levels of circulating proinflammatory cytokines and serum C—reactive protein, but little is known about how this inflammatory response affects IBD. “We need to look more closely at how hypoxia may induce inflammation on a molecular level in the intestines,” Dr. Vavricka said.
To read more articles in this watch, click:
Articles in this issue
about 13 years ago
Deep Breath: Optimizing Selection and Use of Medication Devices in COPDover 13 years ago
Health App Wrapover 13 years ago
Generic Drug Act Awaits Final Approvalover 13 years ago
FDA Policies Source of Drug Shortages, House Committee Reportsover 13 years ago
Generic Product Newsover 13 years ago
Can You Read These Rxs?over 13 years ago
Pet Peevesover 13 years ago
Case Studiesover 13 years ago
Rx Drop Boxes: Do They Work?over 13 years ago
Revocation of Pharmacist's License Reviewed by Appellate CourtNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.